GRAFTON DBM T43105JPN

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-01-02 for GRAFTON DBM T43105JPN manufactured by Medtronic Eatontown.

Event Text Entries

[188485939] Outcomes to adverse event: infection. Manufacturing assessment results: two manufacturing records were reviewed and no related deviations or non conformances were observed for the batch a39430 and part t43105jpn. Grafton putty test reports were reviewed (final product sterility, endotoxin, moisture analysis, glycerol content, calcium assay, environmental monitoring). All tests passed. Hcp reviews: as per hcp opinion the infection was not caused by the grafton putty as received, processed and distributed by medtronic. Also hcp reviewed the donor chart, and he did not believed that our product caused the patient? S infection. Donor file & donor eligibility records: the donor charts revealed no additional reports of adverse reactions involving any other organs/tissues recovered from this donor. Recovery of the subject donor tissue was performed using a method appropriate to controlling contamination. There were no deviations from established procedures that may have increased the risk of contamination/cross contamination. All supplies and reagents used during the recovery were in compliance with 21cfr1271. 210. The recovery was performed within the established time and temperature limits for recovery. Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation. Therefore, we are unable to determine the definitive cause of the reported event. Although it is unknown if the device contributed to the reported event, we are filing this mdr for notification purposes. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[188485940] It was reported that the patient underwent posterior cervical fixation at c2-t1 due to cervical spondylosis and the unilateral open-door laminoplasty were performed. In the surgery, 5cc of tissue has been implanted in the patient. Post-op, the patient had infection on same level. Patient underwent revision surgery as a result of this event and the tissue was removed from the infected site.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2246640-2020-00001
MDR Report Key9537273
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-01-02
Date of Report2020-01-01
Date Mfgr Received2019-12-03
Device Manufacturer Date2019-04-16
Date Added to Maude2020-01-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTACIE ZIEMBA
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal38132
Manufacturer Phone9013963133
Manufacturer G1MEDTRONIC EATONTOWN
Manufacturer Street201 INDUSTRIAL WAY WEST
Manufacturer CityEATONTOWN NJ 07724
Manufacturer CountryUS
Manufacturer Postal Code07724
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGRAFTON DBM
Generic NameBONE GRAFTING MATERIAL, HUMAN SOURCE
Product CodeNUN
Date Received2020-01-02
Model NumberNA
Catalog NumberT43105JPN
Lot NumberA39430-020
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC EATONTOWN
Manufacturer Address201 INDUSTRIAL WAY WEST EATONTOWN NJ 07724 US 07724


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2020-01-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.